Abstract
BackgroundFirst-phase ejection fraction (EF1), the left ventricular (LV) ejection fraction (EF) until the time of peak transaortic velocity, is a novel marker of subclinical LV dysfunction able to predict adverse...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have